Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI
- 1 January 2021
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 47 (1) , 172-180
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central‐Eastern European studyCancer Medicine, 2019
- Signet ring cell features with peritoneal carcinomatosis in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are associated with poor overall survivalJournal of Surgical Oncology, 2019
- Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction CancerJAMA Oncology, 2017
- Peritoneal dissemination in early gastric cancer: importance of the lymphatic routeVirchows Archiv, 2016
- Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosisBritish Journal of Surgery, 2006
- Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Peritoneal Carcinomatosis Arising From Gastric CancerArchives of Surgery, 2004
- Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II studyGastric Cancer, 2003
- Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgeryCancer, 1997
- Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis1996
- Peritonectomy procedures1996